145 related articles for article (PubMed ID: 30324292)
41. Commentary on "no to greed".
Hunt DP
South Med J; 2015 Jan; 108(1):65-6. PubMed ID: 25580762
[No Abstract] [Full Text] [Related]
42. Associations Between Industry Payments to Physicians for Antiplatelet Drugs and Utilization of Cardiac Procedures and Stents.
Yanagisawa M; Blumenthal DM; Kato H; Inoue K; Tsugawa Y
J Gen Intern Med; 2022 May; 37(7):1626-1633. PubMed ID: 34378113
[TBL] [Abstract][Full Text] [Related]
43. US drug marketing: how does promotion correspond with health value?
Greenway T; Ross JS
BMJ; 2017 May; 357():j1855. PubMed ID: 28465309
[No Abstract] [Full Text] [Related]
44. Physician characteristics, industry transfers, and pharmaceutical prescribing: Empirical evidence from medicare and the physician payment sunshine act.
Brunt CS
Health Serv Res; 2019 Jun; 54(3):636-649. PubMed ID: 30273976
[TBL] [Abstract][Full Text] [Related]
45. Cross-sectional Analysis of the Relationship between Paranasal Sinus Balloon Catheter Dilations and Industry Payments among Otolaryngologists.
Fujiwara RJT; Shih AF; Mehra S
Otolaryngol Head Neck Surg; 2017 Nov; 157(5):880-886. PubMed ID: 28895455
[TBL] [Abstract][Full Text] [Related]
46. Nonresearch Industry Payments to Radiologists: Characteristics and Associations With Regional Medical Imaging Utilization.
Kokabi N; Junn JC; Xing M; Hemingway J; Hughes DR; Duszak R
J Am Coll Radiol; 2017 Mar; 14(3):418-425.e2. PubMed ID: 28082155
[TBL] [Abstract][Full Text] [Related]
47. Perspectives on the "generic cliff"--pushing and falling.
Curtiss FR
J Manag Care Pharm; 2008 Apr; 14(3):318-21. PubMed ID: 18439056
[No Abstract] [Full Text] [Related]
48. Physician leadership for high-quality care.
Clancy CM
Chest; 2009 Dec; 136(6):1452-1454. PubMed ID: 19995761
[No Abstract] [Full Text] [Related]
49. Assessment of Pharmaceutical Company and Device Manufacturer Payments to Gastroenterologists and Their Participation in Clinical Practice Guideline Panels.
Nusrat S; Syed T; Nusrat S; Chen S; Chen WJ; Bielefeldt K
JAMA Netw Open; 2018 Dec; 1(8):e186343. PubMed ID: 30646328
[TBL] [Abstract][Full Text] [Related]
50. Effects and Trends in Opioid-Related Promotional Payments Between 2014 and 2019: a Panel Data Analysis Among Prescribers in Medicare Part D.
Pope E; Sehgal N
J Gen Intern Med; 2022 Oct; 37(13):3509-3511. PubMed ID: 35212878
[No Abstract] [Full Text] [Related]
51. Are Financial Payments From the Pharmaceutical Industry Associated With Physician Prescribing? : A Systematic Review.
Mitchell AP; Trivedi NU; Gennarelli RL; Chimonas S; Tabatabai SM; Goldberg J; Diaz LA; Korenstein D
Ann Intern Med; 2021 Mar; 174(3):353-361. PubMed ID: 33226858
[TBL] [Abstract][Full Text] [Related]
52. Doctors who take company cash are more likely to prescribe brand name drugs, analysis finds.
McCarthy M
BMJ; 2016 Mar; 352():i1645. PubMed ID: 27000964
[No Abstract] [Full Text] [Related]
53. Ethical relationships between drug companies and the medical profession.
Rosner F
Chest; 1992 Jul; 102(1):266-9. PubMed ID: 1623765
[No Abstract] [Full Text] [Related]
54. Use of cholesterol-lowering medications in the United States from 1991 to 1997.
Siegel D; Lopez J; Meier J
Am J Med; 2000 Apr; 108(6):496-9. PubMed ID: 10781783
[No Abstract] [Full Text] [Related]
55. The effects of pharmaceutical firm enticements on physician prescribing patterns. There's no such thing as a free lunch.
Orlowski JP; Wateska L
Chest; 1992 Jul; 102(1):270-3. PubMed ID: 1623766
[TBL] [Abstract][Full Text] [Related]
56. Changing clinical practice: messages, messengers, and methods.
Stuart ME
HMO Pract; 1996 Sep; 10(3):100-2. PubMed ID: 10160283
[No Abstract] [Full Text] [Related]
57. An insider's perspective: defense of the pharmaceutical industry's marketing practices.
Johar K
Albany Law Rev; 2012-2013; 76(1):299-334. PubMed ID: 23577377
[No Abstract] [Full Text] [Related]
58. Reimbursement policy and androgen-deprivation therapy for prostate cancer.
Wagle DG
N Engl J Med; 2011 Feb; 364(6):579; author reply 580. PubMed ID: 21306259
[No Abstract] [Full Text] [Related]
59. Low-key, low-cost 'education' for physicians sparks savings.
Montague J
Hosp Health Netw; 1993 Jun; 67(11):70. PubMed ID: 8499972
[No Abstract] [Full Text] [Related]
60. Physician response to Medicare fee reductions: changes in the volume of coronary artery bypass graft (CABG) surgeries in the Medicare and private sectors.
Yip WC
J Health Econ; 1998 Dec; 17(6):675-99. PubMed ID: 10339248
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
